Patents Assigned to EnteroMedics Inc.
-
Publication number: 20080021512Abstract: At least one of a plurality of gastrointestinal disorders is treated by stimulating an enteric nervous system of a patient to enhance a functional tone of the enteric nervous system. A treatment includes electrically stimulating a vagus nerve of the patient at a stimulation site proximal to at least one site of vagal innervation of a gastrointestinal organ. The electrical stimulation includes applying a stimulation signal at the stimulation site. An optional proximal electrical blocking signal is applied to the vagus nerve at a proximal blocking site proximal to the stimulation site. The proximal blocking signal is selected to at least partially block nerve impulses at the proximal blocking site.Type: ApplicationFiled: August 13, 2007Publication date: January 24, 2008Applicant: EnteroMedics Inc.Inventors: Mark Knudson, Richard Wilson, Katherine Tweden, Timothy Conrad
-
Publication number: 20070142870Abstract: At least one of a plurality of disorders of a patient characterized at least in part by vagal activity innervating at least one of a plurality of organs of the patient is treated by a method that includes positioning a neurostimulator carrier around a body organ of the patient where the organ is innervated by at least a vagal trunk. An electrode is disposed on the carrier and positioned at the vagal trunk. An electrical signal is applied to the electrode to modulate vagal activity by an amount selected to treat the disorder. The signal may be a blocking or a stimulation signal.Type: ApplicationFiled: January 22, 2007Publication date: June 21, 2007Applicant: EnteroMedics, Inc.Inventors: Mark Knudson, Richard Wilson, Katherine Tweden, Timothy Conrad
-
Publication number: 20070135856Abstract: At least one of a plurality of disorders of a patient characterized at least in part by vagal activity innervating at least one of a plurality of organs of the patient is treated by a method that includes positioning a neurostimulator carrier around a body organ of the patient where the organ is innervated by at least a vagal trunk. An electrode is disposed on the carrier and positioned at the vagal trunk. An electrical signal is applied to the electrode to modulate vagal activity by an amount selected to treat the disorder. The signal may be a blocking or a stimulation signal.Type: ApplicationFiled: January 22, 2007Publication date: June 14, 2007Applicant: EnteroMedics, Inc.Inventors: Mark knudson, Richard Wilson, Katherine Tweden, Timothy Conrad
-
Publication number: 20070135846Abstract: At least one of a plurality of disorders of a patient characterized at least in part by vagal activity innervating at least one of a plurality of organs of the patient is treated by a method that includes positioning a neurostimulator carrier around a body organ of the patient where the organ is innervated by at least a vagal trunk. An electrode is disposed on the carrier and positioned at the vagal trunk. An electrical signal is applied to the electrode to modulate vagal activity by an amount selected to treat the disorder. The signal may be a blocking or a stimulation signal.Type: ApplicationFiled: January 22, 2007Publication date: June 14, 2007Applicant: EnteroMedics, Inc.Inventors: Mark Knudson, Richard Wilson, Katherine Tweden, Timothy Conrad
-
Publication number: 20070135857Abstract: At least one of a plurality of disorders of a patient characterized at least in part by vagal activity innervating at least one of a plurality of organs of the patient is treated by a method that includes positioning a neurostimulator carrier around a body organ of the patient where the organ is innervated by at least a vagal trunk. An electrode is disposed on the carrier and positioned at the vagal trunk. An electrical signal is applied to the electrode to modulate vagal activity by an amount selected to treat the disorder. The signal may be a blocking or a stimulation signal.Type: ApplicationFiled: January 22, 2007Publication date: June 14, 2007Applicant: EnteroMedics, Inc.Inventors: Mark Knudson, Richard Wilson, Katherine Tweden, Timothy Conrad
-
Publication number: 20070135858Abstract: At least one of a plurality of disorders of a patient characterized at least in part by vagal activity innervating at least one of a plurality of organs of the patient is treated by a method that includes positioning a neurostimulator carrier around a body organ of the patient where the organ is innervated by at least a vagal trunk. An electrode is disposed on the carrier and positioned at the vagal trunk. An electrical signal is applied to the electrode to modulate vagal activity by an amount selected to treat the disorder. The signal may be a blocking or a stimulation signal.Type: ApplicationFiled: January 22, 2007Publication date: June 14, 2007Applicant: EnteroMedics, Inc.Inventors: Mark Knudson, Richard Wilson, Katherine Tweden, Timothy Conrad
-
Patent number: 7201757Abstract: The method of the invention includes accessing a juncture of an esophagus and a stomach of the patient on a distal side of a diaphragm. The esophagus and a fundus of the stomach intersect at a cardiac notch located at an original cardiac notch position. A reducing element is placed at the junction with the reducing element selected to reposition the cardiac notch to a position more distal to a lower esophageal sphincter of the patient.Type: GrantFiled: June 20, 2003Date of Patent: April 10, 2007Assignee: EnteroMedics Inc.Inventors: Mark B. Knudson, Katherine S. Tweden, Timothy R. Conrad, John P. Sopp
-
Patent number: 7167750Abstract: At least one of a plurality of disorders of a patient characterized at least in part by vagal activity innervating at least one of a plurality of organs of the patient is treated by a method that includes positioning a neurostimulator carrier around a body organ of the patient where the organ is innervated by at least a vagal trunk. An electrode is disposed on the carrier and positioned at the vagal trunk. An electrical signal is applied to the electrode to modulate vagal activity by an amount selected to treat the disorder. The signal may be a blocking or a stimulation signal.Type: GrantFiled: January 6, 2004Date of Patent: January 23, 2007Assignee: EnteroMedics, Inc.Inventors: Mark B. Knudson, Richard R. Wilson, Katherine S. Tweden, Timothy R. Conrad
-
Patent number: 6860851Abstract: Vulnerable plaque is identified through a diagnostic method by identifying pathologic markers such as C-reactive proteins or pH change generated by the pathologic site. First and second detectors are advanced through a blood vessel with each of the detectors selected to detect the pathological marker. The detectors are spaced apart while seeking the marker. Differential concentration of the pathological marker as measured by the first and second detectors indicates a presence of the pathological site in proximity to at least one of the detectors.Type: GrantFiled: November 27, 2002Date of Patent: March 1, 2005Assignee: EnteroMedics Inc.Inventors: Mark B. Knudson, Timothy R. Conrad, Katherine S. Tweden
-
Publication number: 20040172088Abstract: At least one of a plurality of disorders of a patient associated with vagal activity innervating at least one of a plurality of organs of the patient at an innervation site are treated by positioning a neurostimulator carrier within a body lumen of the patient. An electrode disposed on the carrier is positioned at a mucosal layer of the lumen. An electrical signal is applied to the electrode to modulate vagal activity by an amount selected to treat the disorder. The signal may be a blocking or a stimulation signal.Type: ApplicationFiled: January 6, 2004Publication date: September 2, 2004Applicant: EnteroMedics, Inc.Inventors: Mark B. Knudson, Richard R. Wilson, Katherine S. Tweden, Timothy R. Conrad
-
Publication number: 20040167583Abstract: At least one of a plurality of disorders of a patient characterized at least in part by vagal activity innervating at least one of a plurality of organs of the patient is treated by a method that includes positioning a neurostimulator carrier around a body organ of the patient where the organ is innervated by at least a vagal trunk. An electrode is disposed on the carrier and positioned at the vagal trunk. An electrical signal is applied to the electrode to modulate vagal activity by an amount selected to treat the disorder. The signal may be a blocking or a stimulation signal.Type: ApplicationFiled: January 6, 2004Publication date: August 26, 2004Applicant: EnteroMedics, Inc.Inventors: Mark B. Knudson, Richard R. Wilson, Katherine S. Tweden, Timothy R. Conrad
-
Patent number: 6699275Abstract: An intraluminal stent comprises a reticulated tube having an un-deployed diameter and expandable to an enlarged diameter. When the tube is at the un-deployed diameter, the tube has cell-defining portions with opposing surfaces defining an open cell bounded by the cell-defining portions.Type: GrantFiled: October 11, 2002Date of Patent: March 2, 2004Assignee: EnteroMedics Inc.Inventors: Mark B. Knudson, John P. Sopp, Timothy R. Conrad